Endocervical Lidocaine Spray for Pain Control During Office Hysteroscopy

Kasr El Aini Hospital

Status and phase: Unknown; Phase 3; Phase 2

Conditions: Pain Uterus

Treatments: Drug: Endocervical Lidocaine spray

Study type: Interventional

Funder types: Other

Identifiers

NCT03382743

171217

Details and patient eligibility

About

lidocaine spray is used endocervical before office hysteroscopy to reduce the pain

Full description

5 sprays of Lidocaine is applied 3 minutes before office hysteroscopy

Enrollment: 200 estimated patients

Sex: Female

Ages: 20 to 45 years old

Volunteers: No Healthy Volunteers

Inclusion criteria

Patients indicated for diagnostic hysteroscopy for infertility or AUB. Postmenstrual between days 7 and 11 of the cycle ( except in irregular bleeding)

Exclusion criteria

Contraindication to office hysteroscopy Neurological disorders affecting the evaluation of pain. Previous cervical surgery.

Trial design

Primary purpose: Prevention

Allocation: Randomized

Interventional model: Parallel Assignment

Masking: Single Blind

---

200 participants in 2 patient groups

Group A (Lidocaine group)

Active Comparator group

Description:

5 sprays of endocervical Lidocaine 10% spray ( AstraZeneca, bedforshire) are used 3 minutes before office hysteroscopy

Treatment:

Drug: Endocervical Lidocaine spray

Group B (control group)

No Intervention group

Description:

office hysteroscopy is done without analgesia